W. Yew (Hong Kong, China), R. Duarte (Vila Nova De Gaia, Portugal)
Keynote lecture: MDR/XDR-TB European plan
H. Kluge (Copenhagen, Sweden)
|  |
The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis
D. Falzon, E. Jaramillo, H. Schünemann, Guidelines Development Group (Geneva, Switzerland; Hamilton, Canada)
|   |
Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) patients in Africa
F. Dennis, S. S. Monica, J. Ernesto, Z. Matteo, N. Wilfred, K. Bah (Geneva, Switzerland; Harare, Zimbabwe; Brazzaville, Congo)
| |
Increasing TB drug resistance in Moldova during the 2006-2010
V. Crudu, V. Botnaru, E. Stratan, O. Golisceva, L. Carchilan, N. Moraru, V. Lesan, V. Soltan, G. Blagodeteleva (Chisinau, Republic Of Moldova)
| |
Drug-resistant tuberculosis in Belarus: Results of the first representative survey
A. Skrahina, A. Zalutskaya, S. Evgeni, A. Astrauko, W. Van Gemert, S. Hoffner, V. Rusovich, M. Zignol, H. Hurevich (Minsk, Belarus; Stockholm, Sweden; Geneva, Switzerland)
| |
First second line anti-tuberculosis drug resistance survey in Romania
D. Homorodean, I. Husar, C. Popa, F. Cojocaru, E. Ibraim (Cluj-Napoca, Bucharest, Romania; Dieppe, France)
| |
Successful treatment of multidrug-resistant tuberculosis through a binational consortium
R. Laniado-Laborin, K. Moser, J. Estrada-Guzman, H. Perez (Tijuana, Mexicali, Mexico; San Diego, United States Of America)
| |
Tuberculosis in household contacts of multidrug-resistant tuberculosis patients
L. Grandjean, A. Crossa, R. Gilman, D. Moore (London, United Kingdom; Boston, Baltimore, United States Of America)
| |